Expression and localization of hepcidin in macrophages: a role in host defense against tuberculosis

Fatoumata B Sow1, William C Florence, Abhay R Satoskar

  • 1Department of Microbiology, The Ohio State University, Columbus, OH 43210, USA.

Insights

Hepcidin, an antimicrobial peptide, is expressed in macrophages infected with Mycobacterium tuberculosis. This peptide localizes to phagosomes and inhibits bacterial growth, demonstrating antimycobacterial activity.

Area of Science:

  • Immunology
  • Microbiology
  • Cell Biology

Background:

  • Hepcidin is a liver-produced antimicrobial peptide regulating iron homeostasis.
  • It degrades ferroportin 1, controlling iron absorption and release.
  • Its role in macrophage response to intracellular pathogens was previously unclear.

Purpose of the Study:

  • To investigate hepcidin expression and function in macrophages infected with Mycobacterium avium and Mycobacterium tuberculosis.
  • To determine if hepcidin exhibits direct antimicrobial activity against mycobacteria.

Main Methods:

  • Macrophage cell lines (RAW264.7, THP-1) and primary bone marrow-derived macrophages were infected with mycobacteria.
  • Hepcidin expression (mRNA and protein) was analyzed following stimulation with mycobacteria, IFN-gamma, IL-6, and IL-1beta.
  • Iron loading and chelation effects on hepcidin expression were assessed.
  • Hepcidin localization was visualized using confocal microscopy.
  • Antimycobacterial activity of hepcidin was evaluated in vitro.

Main Results:

  • Mycobacteria and IFN-gamma synergistically induced high levels of hepcidin mRNA and protein in macrophages.
  • IL-6 and IL-1beta did not induce hepcidin expression.
  • Iron loading inhibited IFN-gamma/M. avium-induced hepcidin, while iron chelation increased it.
  • Hepcidin localized to mycobacteria-containing phagosomes in infected, IFN-gamma-activated cells.
  • Hepcidin inhibited Mycobacterium tuberculosis growth in vitro and caused structural damage.

Conclusions:

  • Hepcidin is expressed in macrophages upon infection with Mycobacterium species, particularly in response to IFN-gamma.
  • Hepcidin localizes to phagosomes containing mycobacteria within infected cells.
  • Hepcidin possesses direct antimycobacterial activity, inhibiting growth and causing structural damage to Mycobacterium tuberculosis.

Related Concept Videos

Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...